Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection
- PMID: 15295706
- DOI: 10.1086/423285
Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection
Abstract
To clarify the pathogenesis of chronic active Epstein-Barr virus (EBV) infection, EBV-specific CD8+ T cells were enumerated, by use of human leukocyte antigen (HLA)-A*2402-restricted tetramers, in 8 patients with chronic active EBV infection, 10 patients with infectious mononucleosis, and 16 EBV-seropositive healthy control subjects. In most of the patients with chronic active EBV infection, EBV-specific CD8+ T cells were not detected. Of note, latent membrane protein 2-specific CD8+ T cells were not detectable in any patients with chronic active EBV infection. In contrast, EBV-specific CD8+ T cells were detected in patients with infectious mononucleosis and in healthy control subjects. Low frequencies of EBV-specific CD8+ T cells may be one of the immunological features of chronic active EBV infection.
Similar articles
-
Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.J Rheumatol. 2005 Feb;32(2):239-51. J Rheumatol. 2005. PMID: 15693083
-
Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.J Med Virol. 2009 May;81(5):870-7. doi: 10.1002/jmv.21445. J Med Virol. 2009. PMID: 19319950
-
Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.Clin Immunol. 2006 Apr;119(1):16-20. doi: 10.1016/j.clim.2005.11.009. Epub 2006 Jan 4. Clin Immunol. 2006. PMID: 16386961
-
[Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].Rinsho Ketsueki. 2000 Jun;41(6):487-90. Rinsho Ketsueki. 2000. PMID: 10921347 Review. Japanese. No abstract available.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
Cited by
-
Chronic Active Epstein-Barr Virus Disease.Front Immunol. 2017 Dec 22;8:1867. doi: 10.3389/fimmu.2017.01867. eCollection 2017. Front Immunol. 2017. PMID: 29375552 Free PMC article. Review.
-
Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.PLoS Pathog. 2011 Oct;7(10):e1002326. doi: 10.1371/journal.ppat.1002326. Epub 2011 Oct 20. PLoS Pathog. 2011. PMID: 22028658 Free PMC article.
-
Epstein-Barr Virus-Associated Aggressive Natural Killer Cell Leukemia: Challenges and Emerging Therapies.Cureus. 2024 Aug 6;16(8):e66338. doi: 10.7759/cureus.66338. eCollection 2024 Aug. Cureus. 2024. PMID: 39246900 Free PMC article.
-
Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.Front Pediatr. 2019 Jan 4;6:417. doi: 10.3389/fped.2018.00417. eCollection 2018. Front Pediatr. 2019. PMID: 30662890 Free PMC article. Review.
-
Updated guidelines for chronic active Epstein-Barr virus disease.Int J Hematol. 2023 Nov;118(5):568-576. doi: 10.1007/s12185-023-03660-5. Epub 2023 Sep 20. Int J Hematol. 2023. PMID: 37728704 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials